We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Exelixis, Inc.

Bumble (NASDAQ:BMBL – Free Report) had its price objective reduced by The Goldman Sachs Group from $10.00 to $8.00 in a report published on Monday morning,Benzinga reports. They currently have a buy ...

Learn more about whether The Carlyle Group Inc. or The Goldman Sachs Group, Inc. is a better investment based on AAII's A+ ...

Navigating market shifts? Explore Goldman Sachs' insights on U.S. growth downgrades, global risks, and diversification ...

Following the S&P 500's recent 10% drawdown, RBC Capital Markets head of US equity strategy Lori Calvasina lowered her ...

The Long Island Association, the region’s largest business group, has appointed Steven Kent as the chief economist of the LIA ...

Three is a trend, as RBC Capital Markets joined Goldman Sachs and Yardeni Research in slashing S&P 500 price targets.

The macroeconomic outlook for the US remains uncertain as the second Trump administration appears to have a higher tolerance ...

Four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...

Goldman Sachs has big price targets on two high-yield tobacco stocks. They can provide investors with reliable streams of ...

Goldman Sachs Asset Management is trying to serve more investors looking for downside protection from market turmoil. Bryon ...

The revised estimates put Wall Street's average year-end target for the S&P 500 at 6,607, implying an advance of more than 17% from Friday's close of 5,638.94, according to a recent survey of Wall ...